Beth Phillips

Search results

• 2022

  Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

  Santarsieri, A., Mitchell, E., Sturgess, K., Brice, P., Menne, T., Osborne, W., Creasey, T., Ardeshna, K., Behan, S., Bhuller, K., Booth, S., Chavda, N., Collins, G., Culligan, D., Cwynarski, K., Davies, A., Downing, A., Dutton, D., Furtado, M. & Gallop-Evans, E. & 26 others, Hodson, A., Hopkins, D., Hsu, H., Iyengar, S., Jones, S., Linton, K., Lomas, O., Martinez-Calle, N., Mathur, A., McKay, P., Nagumantry, S., O'Mahony, D., Phillips, E., Phillips, N., Rudge, J., Shah, N., Stafford, G., Sternberg, A., Trickey, R., Uttenthal, B., Wetherall, N., McMillan, A., Stratton, M., Laurenti, E., Campbell, P. & Follows, G., 15 Nov 2022, In: Blood. 140, p. 1761-1764 4 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2021

  Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp

  Santarsieri, A., Sturgess, K., Brice, P., Menne, T., Osborne, W., Creasey, T., Ardeshna, K., Behan, S., Bhuller, K., Booth, S., Collins, G., Cwynarski, K., Davies, A., Furtado, M., Gallop-Evans, E., Hodson, A., Iyengar, S., Jones, S., Linton, K. & Martinez-Calle, N. & 14 others, Mckay, P., Nagumantry, S., O'Mahony, D., Phillips, B., Phillips, N., Rudge, J., Shah, N., Stafford, G., Sternberg, A., Trickey, R., Uttenthal, B., Wetherall, N., McMillan, A. & Follows, G., 23 Nov 2021, In: Blood. 138, 6 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review